BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28093616)

  • 1. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
    Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
    J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
    Villacis RA; Miranda PM; Gomy I; Santos EM; Carraro DM; Achatz MI; Rossi BM; Rogatto SR
    Int J Cancer; 2016 Apr; 138(8):1928-35. PubMed ID: 26620301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.
    Pirini F; Tedaldi G; Danesi R; Cangini I; Tumedei MM; Ferrari A; Vitali S; De Maio G; Terragna C; Solli V; Tebaldi M; Puccetti M; Zampiga V; Ravegnani M; Ulivi P; Falcini F; Martinelli G; Calistri D
    Int J Colorectal Dis; 2019 Nov; 34(11):1999-2002. PubMed ID: 31655866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
    Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
    Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2.
    Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.
    Kloor M; Voigt AY; Schackert HK; Schirmacher P; von Knebel Doeberitz M; Bläker H
    J Clin Oncol; 2011 Jan; 29(2):223-7. PubMed ID: 21115857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
    Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
    Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification.
    Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A
    Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number variation analysis and targeted NGS in 77 families with suspected Lynch syndrome reveals novel potential causative genes.
    Kayser K; Degenhardt F; Holzapfel S; Horpaopan S; Peters S; Spier I; Morak M; Vangala D; Rahner N; von Knebel-Doeberitz M; Schackert HK; Engel C; Büttner R; Wijnen J; Doerks T; Bork P; Moebus S; Herms S; Fischer S; Hoffmann P; Aretz S; Steinke-Lange V
    Int J Cancer; 2018 Dec; 143(11):2800-2813. PubMed ID: 29987844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of the PREMM
    Kastrinos F; Uno H; Ukaegbu C; Alvero C; McFarland A; Yurgelun MB; Kulke MH; Schrag D; Meyerhardt JA; Fuchs CS; Mayer RJ; Ng K; Steyerberg EW; Syngal S
    J Clin Oncol; 2017 Jul; 35(19):2165-2172. PubMed ID: 28489507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.
    Huth C; Kloor M; Voigt AY; Bozukova G; Evers C; Gaspar H; Tariverdian M; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Mod Pathol; 2012 Jun; 25(6):911-6. PubMed ID: 22388758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy Number Variants Captured by the Array Comparative Genomic Hybridization in a Cohort of Patients Affected with Hereditary Colorectal Cancer in Sri Lanka: The First CNV Analysis Study of the Hereditary Colorectal Cancer in the Sri Lankan Population.
    Wijesiriwardhana P; Wettasinghe K; Dissanayeke VHW
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1957-1966. PubMed ID: 34181357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.
    Chen W; Ding J; Jiang L; Liu Z; Zhou X; Shi D
    Funct Integr Genomics; 2017 Jan; 17(1):85-96. PubMed ID: 27896456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate predisposing germline copy number variants in early onset colorectal cancer patients.
    Brea-Fernandez AJ; Fernandez-Rozadilla C; Alvarez-Barona M; Azuara D; Ginesta MM; Clofent J; de Castro L; Gonzalez D; Andreu M; Bessa X; Llor X; Xicola R; Jover R; Castells A; Castellvi-Bel S; Capella G; Carracedo A; Ruiz-Ponte C
    Clin Transl Oncol; 2017 May; 19(5):625-632. PubMed ID: 27888432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare copy number alterations and copy-neutral loss of heterozygosity revealed in ameloblastomas by high-density whole-genome microarray analysis.
    Diniz MG; Duarte AP; Villacis RA; Guimarães BVA; Duarte LCP; Rogatto SR; Gomez RS; Gomes CC
    J Oral Pathol Med; 2017 May; 46(5):371-376. PubMed ID: 27682262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large germline copy number variations as predisposing factor in childhood neoplasms.
    Krepischi AC; Capelli LP; Silva AG; de Araújo ÉS; Pearson PL; Heck B; da Costa CM; de Camargo B; Rosenberg C
    Future Oncol; 2014; 10(9):1627-33. PubMed ID: 25145432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome.
    Liu Q; Hesson LB; Nunez AC; Packham D; Williams R; Ward RL; Sloane MA
    Carcinogenesis; 2016 Jan; 37(1):10-17. PubMed ID: 26498247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.